Recognition of heparan sulfate by clinical strains of dengue virus serotype 1 using recombinant subviral particles. Artpradit C, Robinson LN, Gavrilov BK, Rurak TT, Ruchirawat M, Sasisekharan R Virus Res176p69-77(2013 Sep)

28 Dec 2013
0
0

Recognition of heparan sulfate by clinical strains of dengue virus serotype 1 using recombinant subviral particles.
Artpradit C, Robinson LN, Gavrilov BK, Rurak TT, Ruchirawat M, Sasisekharan R
Virus Res176p69-77(2013 Sep)

Tags

Share this

Related Posts

Cholinergic activation enhances retinoic acid-induced differentiation in the human NB-4 acute promyelocytic leukemia cell line. Chotirat S, Suriyo T, Hokland M, Hokland P, Satayavivad J, Auewarakul CU. Blood Cells Mol Dis 2016; 59: 77-84.
01 Jul 2016
0

Cholinergic activation enhances retinoic acid-induced differentiation in the human NB-4 acute promyelocytic leukemia cell line. Chotirat S, Suriyo T, Hokland M, Hokland P, Satayavivad J, Auewarakul CU. Blood Cells Mol Dis 2016; 59: 77-84.

Cholinergic activation enhances retinoic acid-induced differentiation in the human NB-4 acute promyelocytic leukemia cell line. Chotirat S, Suriyo T, Hokland M, Hokland P, Satayavivad J, Auewarakul CU. Blood Cells Mol Dis 2016; 59: 77-84.
View More
Longan (Dimocarpus longan Lour.) inhibits liposaccharide-stimulated nitric oxide production in macrophages by suppressing NF-kB and AP-1 signaling pathways. Kunworarah N, Rankadilok N, Suriyo T, Thiantanawat A, Satayavivad J. J Ethnopharmacol 2016; 179: 156-61.
17 Feb 2016
0

Longan (Dimocarpus longan Lour.) inhibits liposaccharide-stimulated nitric oxide production in macrophages by suppressing NF-kB and AP-1 signaling pathways. Kunworarah N, Rankadilok N, Suriyo T, Thiantanawat A, Satayavivad J. J Ethnopharmacol 2016; 179: 156-61.

Longan (Dimocarpus longanLour.) inhibits liposaccharide-stimulated nitric oxide production in macrophages by suppressing NF-kB and AP-1 signaling pathways. Kunworarah N, Rankadilok N, Suriyo T, Thiantanawat A, Satayavivad J. J Ethnopharmacol 2016; 179: 156-61.
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
20 Sep 2023
0

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More